{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T18:02:27Z","timestamp":1779300147419,"version":"3.51.4"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,6,7]],"date-time":"2019-06-07T00:00:00Z","timestamp":1559865600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,6,7]],"date-time":"2019-06-07T00:00:00Z","timestamp":1559865600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13063-019-3361-0","type":"journal-article","created":{"date-parts":[[2019,6,7]],"date-time":"2019-06-07T13:02:44Z","timestamp":1559912564000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A prospective, multicenter, randomized OCT study of early neointimal condition at first and second months after BuMA Supreme stent versus XIENCE stent implantation in high-bleeding-risk coronary artery disease patients: study protocol for a randomized controlled trial"],"prefix":"10.1186","volume":"20","author":[{"given":"Bo","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qin Hua","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun Dai","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang Qian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bei","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guo Sheng","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan Qing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu Chen","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zu Yi","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,6,7]]},"reference":[{"issue":"1","key":"3361_CR1","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.jacc.2006.03.042","volume":"48","author":"M Joner","year":"2006","unstructured":"Joner M, Finn AV, Farb A, Mont EK, Kolodgie FD, Ladich E, Kutys R, Skorija K, Gold HK, Virmani R. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol. 2006;48(1):193\u2013202.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"3361_CR2","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.ahj.2013.01.008","volume":"165","author":"P Urban","year":"2013","unstructured":"Urban P, Abizaid A, Chevalier B, Greene S, Meredith I, Morice MC, Pocock S. Rationale and design of the LEADERS FREE trial: a randomized double-blind comparison of the BioFreedom drug-coated stent vs the Gazelle bare metal stent in patients at high bleeding risk using a short (1 month) course of dual antiplatelet therapy. Am Heart J. 2013;165(5):704\u20139.","journal-title":"Am Heart J"},{"issue":"22","key":"3361_CR3","first-page":"4083","volume":"125","author":"M Chen","year":"2012","unstructured":"Chen M, Wang XG, Zheng B, Peng HY, Zhang XY, Zhang B, Huo Y. Investigation of long-term implantation of BuMA stent in a porcine coronary model. Chin Med J. 2012;125(22):4083\u20137.","journal-title":"Chin Med J"},{"issue":"17","key":"3361_CR4","doi-asserted-by":"publisher","first-page":"2026","DOI":"10.4244\/EIJ-D-17-00462","volume":"13","author":"C von Birgelen","year":"2018","unstructured":"von Birgelen C, Asano T, Amoroso G, Aminian A, Brugaletta S, Vrolix M, Hernandez-Antol\u00edn R, van de Harst P, I\u00f1iguez A, Janssens L, et al. First-in-man randomised comparison of the BuMA Supreme biodegradable polymer sirolimus-eluting stent versus a durable polymer zotarolimus-eluting coronary stent: the PIONEER trial. EuroIntervention. 2018;13(17):2026\u201335.","journal-title":"EuroIntervention"},{"issue":"7","key":"3361_CR5","first-page":"806","volume":"10","author":"J Qian","year":"2014","unstructured":"Qian J, Zhang YJ, Xu B, Yang YJ, Yan HB, Sun ZW, Zhao YL, Tang YD, Gao Z, Chen J, et al. Optical coherence tomography assessment of a PLGA-polymer with electro-grafting base layer versus a PLA-polymer sirolimus-eluting stent at three-month follow-up: the BuMA-OCT randomised trial. EuroIntervention. 2014;10(7):806\u201314.","journal-title":"EuroIntervention"},{"issue":"21","key":"3361_CR6","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1056\/NEJMoa1503943","volume":"373","author":"P1 Urban","year":"2015","unstructured":"Urban P1, Meredith IT, Abizaid A, Pocock SJ, Carri\u00e9 D, Naber C, Lipiecki J, Richardt G, I\u00f1iguez A, Brunel P, et al. Polymer-free drug-coated coronary stents in patients at high bleeding risk. N Engl J Med. 2015;373(21):2038\u201347.","journal-title":"N Engl J Med"},{"issue":"5","key":"3361_CR7","first-page":"382","volume":"44","author":"Section of Interventional Cardiology of Chinese Society of Cardiology of Chinese Medical Association; Specialty Committee on Prevention and Treatment of Thrombosis of Chinese College of Cardiovascular Physicians; Editorial Board of Chinese Journal of Cardiology","year":"2016","unstructured":"Section of Interventional Cardiology of Chinese Society of Cardiology of Chinese Medical Association; Specialty Committee on Prevention and Treatment of Thrombosis of Chinese College of Cardiovascular Physicians; Editorial Board of Chinese Journal of Cardiology. Chinese guideline for percutaneous coronary intervention. Zhonghua xin xue guan bing za zhi. 2016;44(5):382\u2013400.","journal-title":"Zhonghua xin xue guan bing za zhi"},{"issue":"12","key":"3361_CR8","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1016\/j.jacc.2011.09.079","volume":"59","author":"GJ Tearney","year":"2012","unstructured":"Tearney GJ, Regar E, Akasaka T, Adriaenssens T, Barlis P, Bezerra HG, Bouma B, Bruining N, Cho JM, Chowdhary S, et al. Consensus standards for acquisition, measurement, and reporting of intravascular optical coherence tomography studies: a report from the International Working Group for Intravascular Optical Coherence Tomography Standardization and Validation. J Am Coll Cardiol. 2012;59(12):1058\u201372.","journal-title":"J Am Coll Cardiol"},{"issue":"20","key":"3361_CR9","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.1093\/eurheartj\/ehs095","volume":"33","author":"P F","year":"2012","unstructured":"F P, Guagliumi G, Mintz GS, Costa M, Regar E, Akasaka T, Barlis P, Tearney GJ, Jang IK, Arbustini E, et al. Expert review document part 2: methodology, terminology and clinical applications of optical coherence tomography for the assessment of interventional procedures. Eur Heart J. 2012;33(20):2513\u201320.","journal-title":"Eur Heart J"},{"issue":"16","key":"3361_CR10","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1016\/j.jacc.2012.08.001","volume":"60","author":"K Thygesen","year":"2012","unstructured":"Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, Joint ESC\/ACCF\/AHA\/WHF Task Force for Universal Definition of Myocardial Infarction; Authors\/Task Force Members Chairpersons, Thygesen K, Alpert JS, White HD, et al. Third universal definition of myocardial infarction. J Am Coll Cardiol. 2012;60(16):1581\u201398.","journal-title":"J Am Coll Cardiol"},{"issue":"9562","key":"3361_CR11","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/S0140-6736(07)60314-6","volume":"369","author":"J Daemen","year":"2007","unstructured":"Daemen J, Wenaweser P, Tsuchida K, Abrecht L, Vaina S, Morger C, Kukreja N, J\u00fcni P, Sianos G, Hellige G, et al. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet. 2007;369(9562):667\u20138.","journal-title":"Lancet"},{"issue":"14","key":"3361_CR12","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1016\/j.jacc.2008.07.006","volume":"52","author":"P Wenaweser","year":"2008","unstructured":"Wenaweser P, Daemen J, Zwahlen M, van Domburg R, J\u00fcni P, Vaina S, Hellige G, Tsuchida K, Morger C, Boersma E, et al. Incidence and correlates of drug-eluting stent thrombosis in routine clinical practice. 4-year results from a large 2-institutional cohort study. J Am Coll Cardiol. 2008;52(14):1134\u201340.","journal-title":"J Am Coll Cardiol"},{"issue":"17","key":"3361_CR13","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1161\/CIRCULATIONAHA.106.683995","volume":"116","author":"S Windecker","year":"2007","unstructured":"Windecker S, Meier B. Late coronary stent thrombosis. Circulation. 2007;116(17):1952\u201365.","journal-title":"Circulation"},{"issue":"11","key":"3361_CR14","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1161\/CIRCULATIONAHA.108.803627","volume":"118","author":"ME Pfisterer","year":"2008","unstructured":"Pfisterer ME. Late stent thrombosis after drug-eluting stent implantation for acute myocardial infarction: a new red flag is raised. Circulation. 2008;118(11):1117\u20139.","journal-title":"Circulation"},{"key":"3361_CR15","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1477-9560-5-15","volume":"5","author":"J Benezet-Mazuecos","year":"2007","unstructured":"Benezet-Mazuecos J, Ibanez B, Badimon JJ. Dual antiplatelet therapy and drug eluting stents: a marriage of convenience. Thromb J. 2007;5:15.","journal-title":"Thromb J"},{"issue":"1","key":"3361_CR16","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jacc.2011.02.022","volume":"58","author":"GW Stone","year":"2011","unstructured":"Stone GW, Rizvi A, Sudhir K, Newman W, Applegate RJ, Cannon LA, Maddux JT, Cutlip DE, Simonton CA, Sood P, Kereiakes DJ, SPIRIT IV Investigators. Randomized comparison of everolimus- and paclitaxel-eluting stents. 2-year follow-up from the SPIRIT (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) IV trial. J Am Coll Cardiol. 2011;58(1):19\u201325.","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"3361_CR17","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1161\/CIRCULATIONAHA.111.058560","volume":"125","author":"L R\u00e4ber","year":"2012","unstructured":"R\u00e4ber L, Magro M, Stefanini GG, Kalesan B, vanDomburg RT, Onuma Y, Wenaweser P, Daemen J, Meier B, J\u00fcni P, et al. Very late coronary stent thrombosis of a newer-generation everolimus-eluting stent compared with earlygeneration drug-eluting stents: a prospective cohort study. Circulation. 2012;125(9):1110\u201321.","journal-title":"Circulation."},{"issue":"10","key":"3361_CR18","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1093\/eurheartj\/ehs086","volume":"33","author":"GG Stefanini","year":"2012","unstructured":"Stefanini GG, Byrne RA, Serruys PW, de Waha A, Meier B, Massberg S, J\u00fcni P, Sch\u00f6mig A, Windecker S, Kastrati A. Biodegradable polymer drug-eluting stents reduce the risk of stent thrombosis at 4 years in patients undergoing percutaneous coronary intervention: a pooled analysis of individual patient data from the ISAR-TEST 3, ISAR-TEST 4, and LEADERS randomized trials. Eur Heart J. 2012;33(10):1214\u201322.","journal-title":"Eur Heart J"},{"issue":"5","key":"3361_CR19","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1161\/CIRCULATIONAHA.110.014514","volume":"124","author":"JL Guti\u00e9rrez-Chico","year":"2011","unstructured":"Guti\u00e9rrez-Chico JL, Regar E, N\u00fcesch E, Okamura T, Wykrzykowska J, di Mario C, Windecker S, van Es GA, Gobbens P, J\u00fcni P, et al. Delayed coverage in malapposed and side-branch struts with respect to well-apposed struts in drug-eluting stents: in vivo assessment with optical coherence tomography. Circulation. 2011;124(5):612\u201323.","journal-title":"Circulation"},{"issue":"9","key":"3361_CR20","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/j.jcin.2011.03.020","volume":"4","author":"J Gomez-Lara","year":"2011","unstructured":"Gomez-Lara J, Radu M, Brugaletta S, Farooq V, Diletti R, Onuma Y, Windecker S, Thuesen L, McClean D, Koolen J, et al. Serial analysis of the malapposed and uncovered struts of the new generation of everolimus-eluting bioresorbable scaffold with optical coherence tomography. JACC Cardiovasc Interv. 2011;4(9):992\u20131001.","journal-title":"JACC Cardiovasc Interv"},{"issue":"12","key":"3361_CR21","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.1253\/circj.CJ-08-1116","volume":"73","author":"K Ishigami","year":"2009","unstructured":"Ishigami K, Uemura S, Morikawa Y, Soeda T, Okayama S, Nishida T, Takemoto Y, Onoue K, Somekawa S, Takeda Y, et al. Long-term follow-up of neointimal coverage of sirolimus-eluting stents\u2014evaluation with optical coherence tomography. Circ J. 2009;73(12):2300\u20137.","journal-title":"Circ J"},{"issue":"6","key":"3361_CR22","first-page":"970","volume":"125","author":"J Qian","year":"2012","unstructured":"Qian J, Xu B, Lansky AJ, Yang YJ, Qiao SB, Wu YJ, Chen J, Hu FH, Yang WX, Mintz GS, et al. First report of a novel abluminal groove filled biodegradable polymer rapamycin-eluting stent in de novo coronary artery disease: results of the first in man FIREHAWK trial. Chin Med J. 2012;125(6):970\u20136.","journal-title":"Chin Med J"},{"issue":"5","key":"3361_CR23","first-page":"1063","volume":"30","author":"CF Liu","year":"2010","unstructured":"Liu CF, Chen YD, Chen L, Sun ZJ, Gai LY, Liu HB, Tian F, Bai QC, Guo K. Optical coherence tomography for evaluation of neointimal proliferation after placement of a new drug eluting stent. Nan Fang Yi Ke Da Xue Xue Bao. 2010;30(5):1063\u20135.","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"issue":"19","key":"3361_CR24","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1016\/j.jacc.2016.03.475","volume":"67","author":"B Xu","year":"2016","unstructured":"Xu B, Gao R, Yang Y, Cao X, Qin L, Li Y, Li Z, Li X, Lin H, Guo Y, et al. Biodegradable polymer-based sirolimus-eluting stents with differing elution and absorption kinetics: The PANDA III Trial. J Am Coll Cardiol. 2016;67(19):2249\u201358.","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"3361_CR25","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1016\/j.jacc.2009.11.049","volume":"55","author":"PW Serruys","year":"2010","unstructured":"Serruys PW, Onuma Y, Garg S, Vranckx P, De Bruyne B, Morice MC, Colombo A, Macaya C, Richardt G, Fajadet J, et al. 5-year clinical outcomes of the ARTS II (Arterial Revascularization Therapies Study II) of the sirolimus-eluting stent in the treatment of patients with multivessel de novo coronary artery lesions. J Am Coll Cardiol. 2010;55(11):1093\u2013101.","journal-title":"J Am Coll Cardiol"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-019-3361-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13063-019-3361-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-019-3361-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,5]],"date-time":"2020-06-05T23:13:20Z","timestamp":1591398800000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-019-3361-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,7]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["3361"],"URL":"https:\/\/doi.org\/10.1186\/s13063-019-3361-0","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,7]]},"assertion":[{"value":"19 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author\u2019s information"}},{"value":"This study has been approved by the Ethics Committee Board of Chinese PLA General Hospital, Beijing, China, which was accredited by the SIDCER\/FERCAP Survey in 2012. Written informed consent was obtained from each patient\/participant for publication of their individual details and accompanying images in this manuscript. The consent form is held by the authors\/by the authors\u2019 institution\/in the patients\u2019 clinical notes.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"335"}}